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1. Introduction 
Myocardial infarction (MI) results in necrosis, inflammation and scar formation in the 
myocardium. Such pathological insults place increasing mechanical demands on surviving 
cardiomyocytes (Boudoulas & Hatzopoulos, 2009). As cardiomyocytes have limited 
regenerative potential, loss of functional healthy tissue and subsequent left ventricular (LV) 
remodelling, eventually leads to pathological hypertrophic cardiomyopathy. Hypertrophy 
of the LV has been documented as a chronic response to MI and invariably progresses to 
heart failure (Hannigan et al., 2007). Chronic heart failure is a major health problem with 
patients experiencing a debilitating quality of life.  
Cardiac remodelling after MI is characterised by progressive and pathological interstitial 
fibrosis. During acute phase of cardiac repair, degradation of myocardial extracellular 
matrix (ECM) coupled with an influx of inflammatory cells and cytokines permits 
deposition of granulation tissue in the infarct region. At the site of tissue injury, 
granulation tissue composes of macrophages, myofibroblasts and neovascularisation. 
Activated myofibroblasts synthesise collagen and other ECM proteins to form dense scar 
tissue in the infarct in response to inflammatory mediators such as angiotensin II (Ang II) 
and transforming growth factor-1 (TGF-1). Macrophages drive the production of TGF-
1, an essential growth factor for fibroblast production, collagen synthesis and inhibition 
of collagen degradation (O'Kane & Ferguson, 1997; Sun & Weber, 2000). At the site of MI, 
increased expression of adhesion molecules (inter-cellular adhesion molecule-1, ICAM-1) 
and chemoattractant cytokines (monocyte chemotactic protein-1, MCP-1) facilitate 
migration of inflammatory cells (e.g. macrophages) enabling scavenging of necrotic 
tissues (Lu et al., 2004). This couples with elevated expression of matrix 
metalloproteinase-1 (MMP-1) results in remodelling of myocardial ECM by degradation 
of existing collagen I and III in the injured myocardium (Lu et al., 2004). Furthermore, 
MMP-9 has been implicated in tissue remodelling by cleaving collagen V at the amino-
terminus (Niyibizi et al., 1994). Consequently, this process compromises structural 
integrity of the ventricles, resulting in myocyte slippage, wall thinning and rupture 
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(Cleutjens et al., 1995b). Derangements in cardiomyocyte-ECM interactions cause the loss 
of cellular tensegrity and initiates anoikis in neighbouring healthy tissue (Michel, 2003). It 
is now well recognised that structural changes in the myocardial ECM can alter collagen-
integrin-cytoskeletal-myofibril relations, thus affecting overall geometry and function of 
the heart (Spinale, 2007).  
In non-cartilaginous tissues like the heart, collagen I, III and V are the predominant subtypes 
of the ECM (Breuls et al., 2009; Linehan et al., 2001). Collagen I is primarily a structural 
element of the myocardial ECM while collagen V represents a minor, but important 
component sequestered within collagen I fibres. However, collagen V levels increase in 
inflammation and scar tissue. The relative resistance of collagen V to mammalian 
collagenases makes it transiently available during tissue remodelling. The temporal 
availability of collagen V during active extracellular remodelling implies that it may play an 
important role in ECM remodelling and tissue stiffness (Breuls et al., 2009; Ruggiero et al., 
1994). In fact, collagen V plays a deterministic role in collagenous fibril structure, matrix 
organisation and stiffness (Fichard et al., 1995).  
Binding of ECM to integrins provides a linkage between the ECM and cellular 
cytoskeleton. Integrins are heterodimeric receptors composed of non-covalently bound  
and  subunits. (Brancaccio et al., 2006). Dynamic integrin-ECM interactions result in 
bidirectional signalling and determines cell morphology, gene expression, migration, 
proliferation, differentiation and death. Perkins et al. (2010) showed that integrin-
mediated adhesion is mandatory for maintenance of the sarcomeric architecture. They 
proposed that disintegration of the Z-line and progressive muscle degeneration can occur 
once the adhesion complex comprising of integrins, talin or integrin linked kinase (ILK) is 
not replenished. In the myocardium, integrins can function as mechanotransducers that 
transmit mechanical ECM cues to the myocyte, resulting in changes to myocyte biology 
and function (Ross & Borg, 2001). Integrins 21, 11, 31, v3, IIb3 are collagen 
binding heterodimers and adhesion to collagen V has been reported to be primarily 
mediated by integrin 21 and 11 (Ruggiero et al., 1994). Integrins 21 and 11 may 
play a significant role in remodelling of the heart where there is increased collagen 
synthesis and collagen V expression, although we have previously shown v3, but not 
21, in a collagen V associated cardiac differentiation of human mesenchymal stem cells 
(hMSCs) (Tan et al., 2010).  
Increased ejection fraction (EF) and fractional shortening (FS) parameters, coupled with a 
reduction in the amount of fibrotic scar tissue have been highlighted following cellular 
therapy (Chacko et al., 2009). Our previous study showed that cardiomyocyte-like cells 
(CLCs) that were differentiated from MSCs, improved systolic performance without 
compromising end-diastolic pressure of the infarcted myocardium when compared to 
MSCs. CLCs may facilitate hemodynamic recovery by preserving tissue elasticity in the 
collagen V-expressing peri-infarct borders. This unique cell/matrix relationship may be 
more conducive to a functionally adaptive remodelling response in maintaining contractile 
efficiency of post-infarcted myocardium (Tan et al., 2010).   
Experimental data show that MSC transplantation inhibits LV remodelling and improves 
heart function in animals with MI (Xu et al., 2005).  Despite the ability of angiogenic 
mechanisms to reduce infarct mass, only partial restoration of ventricular contraction occurs 
as myocytes are not regenerated (Gaudette & Cohen, 2006). In addition, cardiac 
differentiation and retention of surviving transplanted MSCs in-vivo is limited (Feygin et al., 
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2007). Influence of ECM proteins and integrin interactions on MSC differentiation have been 
widely investigated for chrondrogenic and osteogenic differentiation (Djouad et al., 2007; 
Gronthos et al., 2001). Conversely, studies investigating ECM role in cardiac differentiation 
of MSCs is limited. Unravelling of integrin roles in cardiac differentiation of MSCs would 
aid in understanding of mechanisms leading to retention and integration of stem cells in 
myocardium.  
We have previously reported in-vitro differentiation of human MSCs towards CLCs and 
shown that collagen V promoted adhesion and cardiac gene expression in CLCs (Shim et al., 
2004; Tan et al., 2010). In the present study, we further examine the role of individual 
integrins in cardiac differentiation of CLCs.  
2. Materials and methods 
2.1 Isolation and culture of bone marrow derived MSCs 
Bone marrow was isolated from the sternum of patients undergoing open-heart surgery. 
They were collected in 17 IU/ml heparin using a 23-gauge needle. Bone marrow aspirates 
were topped up to 15 ml with Dulbecco’s modified Eagle’s medium-low glucose (DMEM-
LG, GIBCO) supplemented with 10% fetal bovine serum (FBS, Hyclone) and 1% penicillin-
streptomycin (Gibco, Invitrogen). To deplete bone marrow asiprates of mature blood 
lineages, 15 ml of bone marrow blood mixture was overlaid onto 15 ml of Histopaque®-1077 
(Sigma-Aldrich) and centrifuged for 1500 rpm (Kubota Centrifuge) for 30 minutes at 4oC. 
The enriched cell fraction was collected from the interphase, washed once with 5 ml of 
media and centrifuged at 1200 rpm (Kubota Centrifuge) for 10 minutes. Resuspended cells 
were then transferred into tissue culture flasks with basal normal growth medium (NGM) 
comprising DMEM-LG supplemented with 10% FBS for 9 - 11 days to yield plastic adherent 
MSCs. Subconfluent cells were harvested using 1X Trypsin-EDTA solution for endothelial 
cell culture (Sigma-Aldrich), 14 – 21 days after initial plating and maintained as MSCs in 
basal NMG or differentiated towards CLCs in a myogenic differentiation medium (MDM) 
as previously described (Shim et al., 2004).  
Type V collagen (Sigma-Aldrich) and Type I collagen (BD™) were coated on 6-well 
plates or tissue culture flasks at 10g/cm2 for 3 hours at room temperature. Plates and 
flasks were washed twice with phosphate buffered saline (PBS) and kept at 4oC until 
required.  
2.2 Fluorescence microscopy 
Frozen tissue sections of the explanted ventricular rat hearts were fixed in 4% 
paraformaldehyde (PFA), permeabilised with 0.1% Triton X-100, and further blocked in 5% 
bovine serum albumin (BSA). This was followed by overnight incubation at 4oC with 
primary antibodies, including collagen I (Southern Biotech), collagen III (Affinity Bioregent) 
collagen V (Biotrend) and anti--sarcomeric actinin (Sigma-Aldrich) diluted in 1% BSA. 
Sections were incubated with Alexa Fluor® 488/555/660 - conjugated secondary antibodies 
(Molecular Probes) in 0.1% BSA at room temperature for 3 hours before staining the nuclei 
with DAPI. Immunofluorescence microscopy was performed with Zeiss Axiovert 200 M 
fluorescence microscope, using the Metamorph software (version 6.2, Molecular Devices) or 
Leica MZ 16 FA Fluorescence Steromicroscope, using the Leica Application Suite software 
(Version 3.3.0, Leica).  
www.intechopen.com
 
New Advances in Stem Cell Transplantation 
 
186 
2.3 Flow cytometry  
Sternum-derived bone marrow MSCs were differentiated into CLCs and characterised by 
flow cytometry after 14 days in a MDM. CLCs cultured on uncoated, collagen I or V 
coated tissue culture flasks were stained with antibodies directed towards integrin 
subunits 1 (Abcam), 2 (Santa Cruz), v (Fitzgerald), 1 (Chemicon) and 3 (Cell 
Signaling). Cells were treated with Fix & Perm® Cell Permeabilisation Kit (Invitrogen) and 
subsequently blocked in PBS containing 5% BSA, 1% FBS and 5 mM 
ethylenediaminetetracetic acid (EDTA) for 30 minutes at 4oC on a roller. CLCs were then 
incubated with directly conjugated antibodies for 30 minutes at 4oC. Indirectly conjugated 
antibodies were incubated for 2 hours at 4oC and subsequently stained with their 
respective Alexa Fluor® 555 conjugated secondary antibodies (Invitrogen) for 2 hours at 
4oC. Isotype controls were stained in parallel with the test samples. Samples were washed 
in PBS containing 2% BSA, 2% FBS and 5 mM EDTA after each antibody staining and 
fixation step. All samples were fixed in PBS containing 4% PFA/PBS, washed and 
resuspended in PBS containing 2% FBS and 0.09% sodium azide (NaZ). Data analysis was 
performed using FACSDiva software (version 6.1.2, BDTM), FlowJo software (version 6.4, 
Tree Star, Inc.). Histogram overlays were performed and the change in median 
fluorescence intensity and overton subtraction percentages were computed. 
2.4 Integrin neutralisation assays 
Integrin neutralisation assays were performed on CLCs using neutralising antibodies 
against the integrin 1 (Millipore) subunit and v3 (Millipore) heterodimer, at 1g/ml 
and 10 g/ml respectively. CLCs treated with 1g/ml or 10 g/ml isotype IgG 
(Abcam/Dako) antibodies and untreated CLCs served as controls. After trypsin 
digestion, CLCs were incubated with neutralising and isotype control antibodies for 2 
hours at 4oC. 50,000 untreated and treated CLCs were seeded on collagen V pre-coated 6-
well plates. Plated CLCs were harvested after 72 hours of culture at 37oC, 5% CO2. Total 
RNA was extracted using the RNeasy Mini Kit (Qiagen) and treated with RNAse free 
DNase solution (Qiagen). DNAse treated RNA samples were stored at -80oC until 
required. 
2.5 Real-time reverse transcriptase polymerase chain reaction for quantitation of 
cardiac gene expression 
First strand cDNA was synthesised from total RNA using the SuperScript™ III First-
Strand Synthesis System (Invitrogen) and equal concentrations of cDNA were loaded into 
tubes containing QuantiFast SYBR Green PCR mastermix (Qiagen). Real-time reverse 
transcriptase polymerase chain reaction (RT-PCR) was performed on the Rotor-Gene Q 
thermocycler (Qiagen) using standard cycling parameters and relative gene expression of 
the following cardiac transcripts was quantitated using the CT method. These 
transcripts include  actin (BA), cardiac -actin (CAA), skeletal muscle -actin (SKAA), 
troponin T (Trop T), troponin C (Trop C), Nkx2.5 and GATA4 (Sigma-Aldrich). Target 
gene expression values were normalised relative to the untreated CLCs. BA served as a 
housekeeping gene for the real time RT-PCR experiments. No template controls were 
concurrently processed with test samples to rule out the presence of contaminated 
reagents and nucleic acids.  
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Table 1. Primer sequences for real time reverse transcriptase polymerase chain reaction (RT-
PCR). Transcripts obtained from RT-PCR assays were all less than 200 bp. CAA, cardiac -
actin; SKAA, skeletal muscle -actin; Trop T, troponin T; Trop C, troponin C; BA,  actin. 
2.6 Cell labelling 
CLCs were labelled with 1 mmol/L Vybrant CellTracker chloromethyldialkylcarbocyanie 
(CM-Dil; Molecular Probes) overnight at 37C and rinsed 3 times before trypsin disgestion 
and transplantation. MSCs were labelled with 10mmol/L Vybrant carboxy fluorescein 
diacetate succinimidyl ester (CFDA-SE; Molecular Probes). Cells were resuspended in a final 
concentration of 1 x 106/0.1 ml to 5 x 106/0.2 ml. 
2.7 Rat myocardial infarction model 
MI was created in n=20 female Wistar rats per group. Each rat weighed approximately 350 -
400g in body weight. The animals were subjected to left thoracotomy and the left anterior 
descending artery (LAD) was exposed and ligated. After which rats were allowed a week 
for recovery before given treatment of either injection with labelled cells or placebo to the 
area of infarction. Cyclosporin A was administered at a dose of 5mg/kg body weight at 3 
days before and daily following treatment for 6 weeks until end point.  
2.8 Echocardiography 
Baseline echocardiography was performed on each rat before MI and 6 weeks after 
treatment. Echocardiography images were acquired using Vivid 7 ultrasound machine 
(General Electric VingMed) equipped with i13L linear probe operated at 14MHz. Rats were 
anaesthetised using 1% - 2% isofluorane with 1L/hr oxygen and then fixed in the supine 
position on a heated platform. Rats were then shaved at the chest and abdominal areas 
before electrocardiography (ECG) electrodes were placed onto the left and right leg as well 
as the left upper extremity. All analysis was performed offline with EchoPAC workstation 
(General Electric Healthcare). 
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2.9 Statistical analysis 
One-way analysis of variance (ANOVA) was used to determine statistical significance 
between different treatment groups. Tukey Honestly Significant Difference (HSD) post-hoc 
analyses were used to determine statistical significance between treatment groups using 
SPSS 13 software (SPSS Inc.). p < 0.05 was considered statistically significant.  All data are 
presented as mean  standard deviation (SD).  
3. Results 
3.1 Integrin expression and cardiac differentiation 
Flow cytometric analysis showed that v and 1 were the predominant subunits of integrins 
in CLCs, independent of substrate surface (Table 2). In comparison to collagen V matrix, 
CLCs cultured on collagen I showed a higher expression of integrin 1 (59.4 ± 13.7% vs. 78.0 
± 0.9%) and 3 (44.7 ± 10.6% vs. 56.0 ± 21.8%) subunits. Furthermore, with the exception of 
1 subunit, 2, v, 1 and 3 integrins in CLCs cultured on either collagen matrices showed a 
reduction of expression in comparison to CLCs cultured on polystyrene tissue culture 
surface.    
 
 
Table 2. Flow cytometric analysis showed that integrin v and 1 were the predominant 
subunits in CLCs.  CLCs cultured on collagen I showed increased levels of 1 and 3. Data were 
derived from 3 independent experiments and the overton percentage positive results are 
expressed as mean ± SD. MSCs, Mesenchymal stem cells; CLCs, Cardiomyocyte-like cells.    
3.2 CLCs enhance cardiac gene expression via integrin 1 and v3 on collagen V 
matrices 
We previously reported that collagen V matrix enhanced cardiac gene expression when 
compared to CLCs seeded on collagen I matrix. Collagen V selectively upregulated 
expression of cardiac transcription factors (GATA4, Nkx2.5), calcium handling transporter 
(RyR2) and sarcomeric myofilament proteins (Trop T, Trop C, SKAA) in CLCs (Tan et al., 
2010). Neutralisation of v3 integrin or 1 subunit in this study did not affect CAA and 
SKAA gene expression in CLCs that were cultured on collagen V matrix. Furthermore, no 
significant changes in Nkx2.5 or GATA4 expression was observed in 1 subunit neutralised 
CLCs. However, Nkx2.5 down regulation was observed in CLCs neutralised with v3, 
although similar down regulation was also evident in the isotype control experiment. Gene 
expression of Trop C reduced significantly after v3 integrin neutralisation. In contrary, 1 
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subunit neutralisation upregulated Trop C expression. Furthermore, there was a 
concomitant upregulation of Trop T following 1 integrin neutralisation.  
 
 
Table 3. CLCs cultured on collagen V were treated with integrin 1 (1 g/ml) neutralising 
antibodies. Untreated and isotype IgG (1 g/ml) treated CLCs served as controls for this 
experiment. Optimal concentrations of test and control antibodies were predetermined in a 
series of titration experiments. CLCs cultured on collagen V were treated with integrin v3 
(10 g/ml) neutralising antibodies. Untreated and isotype IgG (10 g/ml) treated CLCs 
served as controls for this experiment. Results are expressed as mean ± SD. CAA, cardiac -
actin; SKAA, skeletal muscle -actin; Trop T, troponin T; Trop C, troponin C, N.D., not 
done; MSCs, Mesenchymal stem cells; CLCs, Cardiomyocyte-like cells. 
3.3 CLCs integrate into collagen V-rich cardiac syncytium 
Consistent with our previous report (Tan et al., 2010), collagen I as the main constituent of 
cardiac ECM in intact rat myocardium, was found to co-localise with collagen III matrix in  
the epicardium and perimysial space between major muscle bundles dispersed throughout 
the myocardium (Fig. 1A). On the other hand, collagen V was predominantly observed in 
the endomysial space surrounding healthy cardiomyocytes and in the perivascular 
structures within the myocardium. Following MI by ligating the LAD artery, significant wall 
thinning was observed in the anterior wall of the LV (Fig.1B). Accumulation of collagen 
matrices was evident in the infarcted and non-infarcted zones 7 weeks post infarction. 
Spatial remodelling and redistribution of collagen matrices were observed whereby 
perimysial collagen I diminished significantly and upregulation of collagen I and III were 
observed in the pericardium and epicardium of infarcted as well as non-infarcted zones. 
Furthermore, fibrosis consisted mainly of collagen I matrix was prominently found in the 
endocardium of infarcted zone while it co-localised with collagen III matrix in the 
pericardium/epicardium of the non-infarcted and infarcted zones (Fig. 1Bii & 1Biii). In 
contrast, collagen V fibrils were sparsely detected in the epicardium of infarct, but were 
prominently found in the peri-vascular structures within the infarct (Fig. 1Biii). In contrast 
to redistribution of collagen I matrix, collagen V remained in the endomysial matrix of 
individual muscle fibres in the non-infarcted borders (Fig.1Bii) and also surrounding 
isolated, but viable cardiac fibres in the infarct.  
Myocardial transplanted CLCs were closely associated with collagen V matrix in the 
endomysial space in the peri-infarct border of the myocardium (Fig. 2A). In contrast, 
similarly transplanted MSCs were only found in collagen I-rich infarct despite the presence 
of isolated, collagen V-expressing, myofibres at the infarct borders (Fig. 2B). Furthermore, 
CLCs were often intimately engrafted among -actinin stained native cardiomyocytes that 
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were surrounded by collagen V, but not collagen I, matrices (Fig. 2C and 2D). On the 
contrary, transplanted MSCs were sequestered in the infarct that was dominated with 
collagen I matrix and isolated from viable and -actinin stained myocardium that expressed 
collagen V matrix (Fig. 2E).  
 
 
Fig. 1. (A) Collagen distribution in an intact myocardium. (Ai) Higher magnification of the 
boxed area showing collagen I and III distribution in the perimysium while collagen V was 
expressed in the endomysial space. (B) Collagen distribution in an infarcted myocardium. 
(Bii) Higher magnification of the myocardium, epicardium and pericardium at the boxed 
area. Collagen V was predominantly expressed at the peri-infarct border surrounding viable 
myocytes and vasculature structures in the infarct region. Collagen I and III were positively 
stained in the infarcted epicardium and pericardium. (Biii) Higher magnification 
demonstrating severe thinning of the LV anterior wall. Co-localisation of collagen I and III 
extended from the pericardium into the infarcted myocardium whereas collagen I was 
primarily localised in the endocardium. Collagen V was expressed in the vessels and 
sparsely  in the infarct. Scale bar: 200µm.  
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Fig. 2. (A) Transplanted CLCs preferentially home to the collagen V-rich myocardial ECM. 
(B) Transplanted MSCs localised in the collagen I enriched infarct zone away from the 
collagen V peri-infarct region. (C) Engraftment of CLCs in the -actinin stained 
myocardium (D) showing an affinity towards collagen V matrix in the absence of collagen 
I staining. (E) MSCs were embedded in the collagen I-rich infarct zone and were isolated 
from -actinin expressing cardiomyocytes. (F) Collagen V was sparsely distributed in the 
infarcted region, but mainly surrounded viable myocytes at the peri-infarct border. Scale 
bar: 20µm. MSCs: Mesenchymal stem cells; CLCs: Cardiomyocyte-like cells; Col I: 
Collagen I; Col V: Collagen V. 
3.4 CLC therapy at high doses improve cardiac hemodynamics 
Consistent with their muscular engraftment, LV echocardiography confirmed a better 
cardiac performance of transplanted CLCs, 6 weeks post cell transplant (Table 4).  
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Transplanted CLCs (2.2  0.3 mm, p<0.05), but not MSCs (2.1  0.3 mm), improved LV 
anterior wall thickness as compared to control infarcted animal (1.8  0.4 mm). Nevertheless, 
other cardiac parameters indicated that CLCs and MSCs contributed comparably to 




Table 4. Ultrasound echocardiography assessment of post cellular therapy treated rats. 2D 
ultrasound echocardiography assessments showed significant improvements in cell 
transplanted animals. SF: Serum free control; CLC: Cardiomyocyte-like-cells; MSCs: 
Mesenchymal stem cells; LVIDed: Left ventricular internal dimension at end diastolic; LVID: 
Left ventricular internal dimension at end systolic; IVSed: Interventricular septum at end 
diastolic, IVSes: Interventricular septum at end systolic; AWT: Anterior wall thickening; FS: 
Fractional shortening; EF: Ejection fraction. 
4. Discussion  
Integrins and ECM are important modulators of stem cell behaviours. To date, cardiac cell 
therapy supported only modest benefits, likely due to low engraftment of transplanted cells 
in the infarcted myocardium. Exploration of specific integrin/ECM interaction may improve 
engraftment and survival of transplanted cells and ultimately, mechanical function of the 
heart. Our current study examines integrin/ECM interactions on cardiac gene expression of 
CLCs and distribution of transplanted CLCs in infarcted myocardium.  
The distribution and quantity of type I and III collagens in the heart play an important role 
in maintaining cardiac function. Alterations of collagen population and distribution in the 
myocardium affect size and shape of the heart chambers as well as myocardial diastolic and 
systolic function (Cleutjens et al., 1995a; Janicki & Brower, 2002). However, it is unclear if 
such alterations could affect stem cell migration and differentiation in the myocardium.  
We have previously demonstrated that CLCs showed preferential adhesion to collagen V 
over collagen I matrix by interacting with subsets of integrins (Shim et al., 2004; Tan et al., 
2010). van Laake et al. (2010) reported that pre and post transplanted human embryonic 
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cardiomyocytes (hESC-CM) express integrins matching ECM types they encountered in 
their environment. Therefore, the integrin modulating role of collagen V may aid in the 
observed retention of the myocardial transplanted CLCs. Furthermore, intimate engraftment 
of the transplanted CLCs with collagen V-expressing, -actinin positive, native 
cardiomyocytes supports an unique role of collagen V in the myocardium. Moreover, 
differential expression of 1 and 3 integrin between collagen I and V cultured CLCs coupled 
with the preferential homing demonstrated between transplanted MSCs and CLCs suggested 
a key role of collagen V matrix, not only in cellular retention, but cardiac differentiation of the 
transplanted stem cells. This is consistent with modulation of cardiac gene expression of CLCs 
demonstrated in relation to 1 and v3 neutralisation in vitro, although such relationship was 
not examined in vivo. Nevertheless, the comparable cardiac outcomes achieved in spite of 
selective homing of the transplanted cells, indicate that different reparative mechanisms may 
be initiated by MSCs and CLCs. Despite a positive trend of systolic improvement by CLCs, 
further mechanistic studies are warranted to discern their specific contribution to systolic and 
diastolic components of cardiac performance.  
Integrin 1 is known to transduce ECM signals to the cytoskeleton that activate downstream 
mitogen activated protein kinase (MAPK) and extracellular signal-regulated kinase 1 (ERK1) 
signalling pathways that phosphorylate and activate GATA4 (Akazawa & Komuro, 2003). 
However, GATA4 expression was unaffected by integrin 1 neutralisation despite the 
upregulated Trop C and Trop T belonging to downstream genes known to be activated by 
GATA4 (Liang et al., 2001; Tidyman et al., 2003). Similarly, neutralisation of v3 integrin 
attenuated Trop C expression despite GATA4 was previously shown to be unaffected by 
neutralisation of v3 (Tan et al., 2010). It is unclear if the modulation of myofilamental gene 
expression demonstrated was secondary to other nuclear transcription factors. However, 
integrins are known to mechanotransduce signals to activate Raf-MEK-ERK-1/2 cascade 
that has been shown to elicit cardiomyocyte growth, increased fetal-gene expression and 
cytoskeletal reorganisation in neonatal cardiomyocytes (Lorenz et al., 2009). Nevertheless, it 
is unclear if reduced expression of integrin demonstrated on either collagen surface as 
compared to CLCs cultured on uncoated polystrene surface was associated with enhanced 
proliferation of CLCs as previously reported (Tan et al 2010). However, contrary to our 
previous data, SKAA was not down regulated by integrin v3 neutralisation in the current 
study. This could be due to donor variations. Indeed, donor variation in integrin expression 
has been documented from different bone marrow isolates and passage numbers, resulting 
in different growth and proliferation potential (ter Brugge et al., 2002).  
Despite beneficial effects of collagen V on cardiac gene expression and stem cell 
distribution, it should be noted that collagen distribution in the infarcted rat hearts may 
be different from humans during MI. Furthermore, a 3D structure like the heart may 
transmit different environmental cues to integrins as compared to 2D environments 
provided in tissue culture experiments. It remains to be determined whether inhibitory 
antibodies may transactivate other integrin receptors during epitope occupancy. In 
addition, the promiscuity of integrins renders it technically challenging to identify 
whether a single integrin or interplay of synergistic interactions between a few integrins is 
required for regulation of cardiac gene expression. Future studies employing siRNA 
techniques that selectively silence 1 or v3 integrin may provide additional information 
regarding the regulation of cardiac gene expression of CLCs on collagen V matrix ex vivo 
or in the transplanted milieu of infarcted myocardium.  
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In conclusion, our study indicates that 1 and v3 integrins drive cardiac gene expression of 
CLCs. Integrin families and ECM are important regulators of cardiac differentiation and 
myocardial distribution of adult MSCs and CLCs. Specific modulation of interaction 
between subclasses of collagen and integrin subunits in the post-infarct myocardial ECM 
could potentially offer a unique opportunity in cardiac regenerative medicine.    
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